Human normal Immunoglobulin 16% (CSL Behring)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman normal Immunoglobulin 16% (CSL Behring)
Drug Alias NameEvogam
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsImmunologic Deficiency Syndromes
Global Approved IndicationsImmunologic Deficiency Syndromes
Approved Indications in ChinaN/A
Original Approved Country/TerritoryAustralia
Original Approved Date2012/03/01
Country/TerritoryAustralia
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCsl Behring Llc
China Registration ClassN/A

Develop Information

Active CompaniesCsl Behring Llc
Inactive CompaniesN/A
Active IndicationsImmunologic Deficiency Syndromes
Inactive IndicationsN/A

Other Information

ATC CodeJ06BA01
Related LinksN/A